National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 10/15/2021 release of VAERS data:

Found 2,281 cases where Vaccine is COVID19 and Symptom is COVID-19 and Patient Died



Case Details (Sorted by Age)

This is page 5 out of 229

Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12 13 14   next


VAERS ID: 955814 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2020-12-12
Onset:2021-01-01
   Days after vaccination:20
Submitted: 0000-00-00
Entered: 2021-01-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-01-08
   Days after onset: 7
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 20210101; Test Name: COVID-19 virus test; Test Result: Positive ; Comments: Yes - Positive COVID-19 test
CDC Split Type: GBPFIZER INC2021031721

Write-up: COVID-19 virus test and revealed yes - positive COVID-19 test/SARS-CoV-2 infection; COVID-19 virus test and revealed yes - positive COVID-19 test/sars-cov-2 infection; This is a spontaneous report downloaded from the Regulatory Authority. Regulatory authority number: GB-MHRA-ADR 24581491. A contactable physician reported that an elderly male patient of unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 12Dec2020 at single dose for COVID-19 immunisation. Medical history was not reported. The patient''s concomitant medications were not reported. Patient is not enrolled in clinical trial. The patient was suspected COVID-19 but unsure when symptoms started. She underwent COVID-19 virus test and revealed yes - positive COVID-19 test on 01Jan2021. She experienced sars-cov-2 infection on 01Jan2021 with outcome of fatal. The patient died on 08Jan2021, cause of death was COVID-19 virus test and revealed yes - positive COVID-19 test/sars-cov-2 infection. It was unknown if an autopsy was performed. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender''s Comments: The association between the event lack of effect (fatal SARS CoV2 infection) with BNT162b2 can not be fully excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.; Reported Cause(s) of Death: COVID-19 virus test and revealed yes - positive COVID-19 test/sars-cov-2 infection; COVID-19 virus test and revealed yes - positive COVID-19 test/sars-cov-2 infection


VAERS ID: 960059 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2020-12-29
Onset:2021-01-01
   Days after vaccination:3
Submitted: 0000-00-00
Entered: 2021-01-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH 011035926710001 / UNK - / OT

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Cerebrovascular accident, Death, Drug ineffective, SARS-CoV-2 test
SMQs:, Lack of efficacy/effect (narrow), Ischaemic central nervous system vascular conditions (narrow), Haemorrhagic central nervous system vascular conditions (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died: 2021-01-04
   Days after onset: 3
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Name: PCR; Test Result: Positive
CDC Split Type: DEPFIZER INC2021039253

Write-up: Unknown cause of death; COVID-19; COVID-19; Apoplexy; This is a spontaneous report from a non-contactable physician. This is a report received from the Medicines Agency (MA) Regulatory Authority-WEB. Regulatory authority or other manufacturer number DE-PEI-PEI2021000691. An 87-year-old male patient received BNT162B2 (COMIRNATY, lot/batch number 0110359267100013) intramuscularly at a single dose on 29Dec2020 for COVID-19 prophylaxis. The patient''s medical history and concomitant medications were not reported. On 01Jan2021, the patient developed Apoplexy, on 02Jan2021, patient developed COVID-19 and on 04Jan2021, patient experienced unknown cause of death. The patient was dead and condition was life threatening. Lab tests included PCR positive on an unspecified date. Follow-up information has been requested.; Reported Cause(s) of Death: Covid-19; Covid-19; Apoplexy; Unknown cause of death


VAERS ID: 960101 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2020-12-16
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-01-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ0553-L449 / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Drug ineffective, Sepsis
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (broad), Sepsis (narrow), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2020-12-31
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Urinary tract infection
Allergies:
Diagnostic Lab Data:
CDC Split Type: GBPFIZER INC2021027969

Write-up: drug ineffective; COVID-19; Sepsis; This is a spontaneous report from a contactable physician downloaded from the Regulatory Authority-WEB manufacturer report number GB-Regulatory Authority-WEBCOVID-20210107092914. An 82-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, LOT#: EJ0553-L449), via an unspecified route of administration on 16Dec2020 at single dose for covid-19 immunisation. The patient medical history included urinary tract infection. Patient has not had symptoms associated with COVID-19. Patient has not been tested/or has had an inconclusive test for COVID-19. Patient is not enrolled in clinical trial. The patient''s concomitant medications included antibiotics for urinary tract infection. The patient died on 31Dec2020. Probably unrelated to vaccine but patient died of covid. The patient had a minor urinary tract infection and was on antibiotics. Clinically well and no sepsis. However admitted to hospital soon after with sepsis and died. It was not reported if an autopsy was performed. Outcome of the events was fatal. No follow-up attempts possible. No further information expected. Lot/batch number was provided.; Reported Cause(s) of Death: COVID-19; Sepsis


VAERS ID: 961901 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: Foreign  
Vaccinated:2021-01-06
Onset:2021-01-01
Submitted: 0000-00-00
Entered: 2021-01-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-01-01
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 202101; Test Name: Covid tested; Test Result: Positive
CDC Split Type: DEPFIZER INC2021039029

Write-up: sick with Covid 19 and died after the vaccination. Covid positive after the first vaccination; sick with Covid 19 and died after the vaccination. Covid positive after the first vaccination; This is a spontaneous report from a contactable physician, based on information received by Pfizer from Biontech (manufacturer control number: not provided), license party for BNT162B2. The physician reported similar events for 2 patients. This is the case for the first of 2 patients. An elderly patient of an unspecified gender received the first dose of BNT162b2 (COMIRNATY,Lot/Batch Number and Expiration Date unknown), via an unspecified route of administration on 06Jan2021 at 1 dose form (DF) single dose for covid-19 prophylaxis. The patient''s medical history and concomitant medications were not reported. It was reported that the physician was a vaccinator of a vaccination center and on 06Jan2021, 07Jan2021 and 08Jan2021 he had vaccinated 3 elderly residents in a nursing home with the vaccine Corminaty. It turned out that 2 of the elderly residents were sick with Covid 19 and died after the vaccination in Jan2021. Covid tested positive after the first vaccination in Jan2021. This patient was vaccinated on 06Jan2021. It was not reported if an autopsy was performed. Information on the lot/batch number has been requested.; Sender''s Comments: Based on the information available, a possible contributory role of the suspect products cannot be excluded for the reported event of positive for corona virus infection for the lack of efficacy of the vaccine. However, based on the mechanism of action of the vaccine, it is unlikely the patient would have fully developed immunity for the vaccine to be effective, due to the number of days passed since the vaccine is given. Case will be reevaluated based on follow-up information,Linked Report(s) : DE-PFIZER INC-2021043240 same Reporter, same events, different patient; Reported Cause(s) of Death: Covid-19; Covid-19


VAERS ID: 961902 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: Foreign  
Vaccinated:2021-01-06
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-01-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Name: COVID; Result Unstructured Data: Test Result:positive after the first vaccination
CDC Split Type: DEPFIZER INC2021043240

Write-up: sick with Covid 19 and died after the vaccination. Covid positive after the first vaccination; sick with Covid 19 and died after the vaccination. Covid positive after the first vaccination; This is a spontaneous report from a contactable physician, based on information received by Pfizer from Biontech (manufacturer control number: not provided), license party for BNT162B2. The physician reported similar events for 2 patients. This is the case for the 2nd of 2 patients. An elderly patient of an unspecified gender received the first dose of BNT162b2 (COMIRNATY), via an unspecified route of administration on 06Jan2021 at single dose for covid-19 prophylaxis. The patient''s medical history and concomitant medications were not reported. It was reported that the physician was a vaccinator of a vaccination center and on 06Jan2021, 07Jan2021 and 08Jan2021 he had vaccinated 3 elderly residents in a nursing home with the vaccine Corminaty. It turned out that 2 of the elderly residents were sick with Covid 19 and died after the vaccination. Covid tested positive after the first vaccination. This patient was vaccinated on 06Jan2021. It was not reported if an autopsy was performed. Information on the lot/batch number has been requested.; Sender''s Comments: Based on the information available, a possible contributory role of the suspect products cannot be excluded for the reported event of positive for corona virus infection for the lack of efficacy of the vaccine. However, based on the mechanism of action of the vaccine, it is unlikely the patient would have fully developed immunity for the vaccine to be effective, due to the number of days passed since the vaccine is given. Case will be reevaluated based on follow-up information,Linked Report(s) : DE-PFIZER INC-2021039029 same Reporter, same events, different patient; Reported Cause(s) of Death: Covid-19; Covid-19


VAERS ID: 962006 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2020-12-23
Onset:2020-12-28
   Days after vaccination:5
Submitted: 0000-00-00
Entered: 2021-01-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Confusional state, Cough, Drug ineffective, Hypoxia, Pyrexia, SARS-CoV-2 test
SMQs:, Anaphylactic reaction (broad), Asthma/bronchospasm (broad), Lack of efficacy/effect (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Dementia (broad), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Eosinophilic pneumonia (broad), Respiratory failure (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-01-11
   Days after onset: 14
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Clinical trial participant (recovery trial); Diabetes; Comments: Diabetes Patient has not had symptoms associated with COVID-19 Not had a COVID-19 test
Allergies:
Diagnostic Lab Data: Test Name: COVID-19 virus test; Test Result: Positive
CDC Split Type: GBPFIZER INC2021040990

Write-up: breathing difficuties; SARS-CoV-2 infection; SARS-CoV-2 infection; Confusional state; Cough; Pyrexia; This is a spontaneous report received by Pfizer from the Medicines and Healthcare products Regulatory Agency (UK-MHRA). The regulatory authority report number is GB-MHRA-WEBCOVID-202101141012341090 and Safety Report Unique Identifier GB-MHRA-ADR 24594185. A contactable healthcare professional reported that an 81-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 23Dec2020 at single dose for COVID-19 immunisation. Medical history included clinical trial participant (recovery trial), and diabetes mellitus. The patient''s concomitant medications were not reported. The patient became unwell experienced breathing difficuties (death) on 28Dec2020, sars-cov-2 infection on 30Dec2020, confusional state on 30Dec2020, cough on 30Dec2020, pyrexia on 30Dec2020. It was explained that the patient had deteriorated on 30Dec2020 with fever, cough, confusion. Admitted to hospital - hypoxic. The patient underwent lab tests and procedures which included COVID-19 virus test: positive on unspecified date (on admission to hospital). Outcome of event breathing difficulties was fatal, of event sars-cov-2 infection was unknown, and of other events was not resolved. The patient died on 11Jan2021. An autopsy was not performed. No follow-up attempts are possible; information about batch number cannot be obtained. No further information is expected.; Reported Cause(s) of Death: Hypoxia


VAERS ID: 971353 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2020-12-27
Onset:2020-12-28
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-01-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ6796 / UNK - / OT

Administered by: Other       Purchased by: ?
Symptoms: Blood test, COVID-19, Drug ineffective, Respiratory failure, SARS-CoV-2 test, Severe acute respiratory syndrome
SMQs:, Anaphylactic reaction (broad), Lack of efficacy/effect (narrow), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (broad), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (broad), Toxic-septic shock conditions (broad), Anaphylactic/anaphylactoid shock conditions (broad), Hypoglycaemic and neurogenic shock conditions (broad), Acute central respiratory depression (narrow), Guillain-Barre syndrome (broad), Hypersensitivity (broad), Respiratory failure (narrow), Infective pneumonia (broad), Hypokalaemia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died: 2020-12-29
   Days after onset: 1
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: COVID-19
Allergies:
Diagnostic Lab Data: Test Date: 20201228; Test Name: Blood test; Result Unstructured Data: Test Result:No results reported; Test Date: 20201228; Test Name: COVID-19 virus test; Test Result: Positive
CDC Split Type: DKPFIZER INC2021054421

Write-up: Respiratory insufficiency / severe acute respiratory syndrome; Respiratory insufficiency / severe acute respiratory syndrome; Respiratory insufficiency / severe acute respiratory syndrome; Respiratory insufficiency / severe acute respiratory syndrome; This is a spontaneous report from a contactable physician downloaded from the Medicines Agency (EMA) EudraVigilance-WEB. This is a report received from the regulatory authority (DKMA). The regulatory authority report number is DK-DKMA-WBS-0028707; Safety Report Unique Identifier DK-DKMA-ADR 24576087. A 91-year-old female patient received the bnt162b2 (COMIRNATY; Lot Number: EJ6796), intramuscularly on 27Dec2020 at a single dose for COVID-19 immunization. The patient''s medical history included COVID-19 from an unknown date and unknown if ongoing. Concomitant medications were not reported. On 28Dec2020, the patient experienced: respiratory insufficiency / severe acute respiratory syndrome; which was assessed as medically significant, life threatening, and resulted in hospitalization and death. The patient was hospitalized for respiratory insufficiency / severe acute respiratory syndrome from 28Dec2020 to an unknown date. The patient underwent lab tests and procedures which included blood test: no results reported on 28Dec2020, COVID-19 virus test: positive on 28Dec2020. The clinical outcome of the event was fatal. The patient died on 29Dec2020 due to respiratory insufficiency / severe acute respiratory syndrome. An autopsy was not performed. Causality: Reporter stated that it cannot be ruled out that the vaccine was a contributing cause, why the death was reported as presumed adverse drug reaction of the vaccine. If the Medicines Agency receives supplemental significant information regarding this case the case will be re-submitted. ADDITIONAL INFORMATION ON DRUG PROVIDED IN PRODUCT NOTES: Previous given: No; Reported Cause(s) of Death: Respiratory insufficiency; severe acute respiratory syndrome


VAERS ID: 976303 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2020-12-29
Onset:2020-12-30
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-01-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ6796 / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Body temperature, Body temperature increased, COVID-19, Crepitations, Drug ineffective, Food refusal, General physical health deterioration, Heart rate, Oxygen saturation, Oxygen saturation decreased, Pneumonia, SARS-CoV-2 test, Tachycardia
SMQs:, Lack of efficacy/effect (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Acute central respiratory depression (broad), Eosinophilic pneumonia (broad), Respiratory failure (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (narrow), Dehydration (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died: 2021-01-07
   Days after onset: 8
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Apoplexy; Bedridden; Cardiac insufficiency; Renal insufficiency; Vascular dementia
Allergies:
Diagnostic Lab Data: Test Date: 20210106; Test Name: Body temperature; Result Unstructured Data: Test Result:37.9 Centigrade; Test Date: 20210106; Test Name: Heart rate; Result Unstructured Data: Test Result:123 / min; Test Date: 20210106; Test Name: Heart rate; Result Unstructured Data: Test Result:in later measurements 102 -106 / min; Test Date: 20210106; Test Name: Oxygen saturation; Result Unstructured Data: Test Result:76-86 %; Test Date: 20210107; Test Name: Oxygen saturation; Result Unstructured Data: Test Result:74-78 %; Comments: dropped; Test Name: post-mortem smear test of SARS-CoV-2; Test Result: Positive ; Comments: Ct value 31
CDC Split Type: DEPFIZER INC2021061562

Write-up: Positive post-mortem smear test of SARS-CoV-2 (Ct value: 31); Positive post-mortem smear test of SARS-CoV-2 (Ct value: 31); crackles; suspicion of pneumonia; body temperature up to 37.9 centigrade; tachycardia (up to 123 /min); oxygen saturation was on 06Jan2021 at 76-80%; food refusal; general condition deteriorated; This is a spontaneous report from a contactable physician. An 83-year-old female patient received first dose of bnt162b2 (COMIRNATY, batch/lot number: EJ6796), via an unspecified route of administration on 29Dec2020 at single dose for covid-19 immunisation. The patient''s concomitant medications were not reported. Patient was a largely bedridden lady, resident of a nursing home with medical history of vascular dementia, renal insufficiency, cardiac insufficiency, and state after apoplexy in Apr2019. Vaccination performed on 29Dec2020. At the time there were already Covid-19 cases in the house, but not in the immediate living area. From 30Dec2020 the general condition deteriorated, she refused to eat more and more and indicated that she wanted to be left alone. On 06Jan2021 she developed body temperature up to 37.9 centigrade and tachycardia up to 123 / min (in later measurements 102-106 / min), the oxygen saturation was on 06Jan2021 at 76-80%. A hospitalization was waived after consultation with the relatives due to the presumed wishes of the patient. On 07Jan2021 patient developed crackles, the saturation dropped to 74-78% and she died at 8:48 a.m. It was suspicion of vaccination reactions. Diagnosis were food refusal from 30Dec2020 to end, and tachycardia and temperature increase, suspicion of pneumonia from 06Jan2021 to end. Diagnosis / suspected diagnosis was supported by the following investigations: positive post-mortem smear test of SARS-CoV-2 (Ct value: 31). Outcome of events general condition deteriorated and crackles was unknown, outcome of other events was fatal. The mentioned vaccines had not been used again after the symptoms subsided. The symptoms of a suspected vaccination complication didn''t recur in patients without a temporal connection. Life-threatening adverse events, ambulatory treatment required, hospitalization refused. The patient died on 07Jan2021. An autopsy was performed. Reported cause of death was positive post-mortem smear test of SARS-CoV-2 (Ct value: 31), suspicion of pneumonia, body temperature up to 37.9 centigrade, tachycardia (up to 123 /min), oxygen saturation was on 06Jan2021 at 76-80% and food refusal.; Sender''s Comments: There is not a reasonable possibility that reported events are related to BNT162B2. Symptoms started 1 day after vaccination. It''s likely that all reported symptoms are due to COVID-19. And it''s reported at the time of vaccination, there were already COVID-19 cases in the house patient lived. Therefore, all reported events are more likely intercurrent medical conditions. The elderly patient''s underlying diseases may also be contributory. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.; Reported Cause(s) of Death: body temperature up to 37.9 centigrade; suspicion of pneumonia; tachycardia (up to 123 /min); food refusal; Positive post-mortem smear test of SARS-CoV-2 (Ct value: 31); Positive post-mortem smear test of SARS-CoV-2 (Ct value: 31); oxygen saturation ; Autopsy-determined Cause(s) of Death: Positive post-mortem smear test of SARS-CoV-2 (Ct value: 31); Positive post-mortem smear test of SARS-CoV-2 (Ct value: 31)


VAERS ID: 976359 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2020-12-19
Onset:2020-12-01
Submitted: 0000-00-00
Entered: 2021-01-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ0553 / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Agitation, COVID-19, COVID-19 pneumonia, Chest X-ray, Cough, Drug ineffective, Dyspnoea, Fall, Investigation, Oxygen saturation, SARS-CoV-2 test, Viral test
SMQs:, Anaphylactic reaction (broad), Lack of efficacy/effect (narrow), Anticholinergic syndrome (broad), Dementia (broad), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Accidents and injuries (narrow), Hostility/aggression (broad), Cardiomyopathy (broad), Hypoglycaemia (broad), Infective pneumonia (narrow), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2020-12-25
   Days after onset: 24
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: ASPIRIN [ACETYLSALICYLIC ACID]; ATORVASTATIN; FERROUS FUMARATE; MEMANTINE; MIRTAZAPINE; OMEPRAZOLE; OXYTETRACYCLINE; RAMIPRIL
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Anaemia; Coronary artery disease; Dementia; Depression; Gastritis erosive; Head injury; Osteoarthritis; Rosacea; Comments: Patient has not had symptoms associated with COVID-19 Patient has not been tested/or has had an inconclusive test for COVID-19. Patient is not enrolled in clinical trial
Allergies:
Diagnostic Lab Data: Test Date: 20201223; Test Name: Chest X-ray; Result Unstructured Data: Test Result:reported that whilst appearances are most likely t; Comments: reported that whilst appearances are most likely to reflect oedema, acute respiratory distress syndrome (ARDS) and atypical infection cannot be excluded; Test Date: 20201223; Test Name: examination; Result Unstructured Data: Test Result:bilateral crepitus; Comments: No focal neurological deficit was found on examination, 4 limbs power 5/5; Test Date: 20201223; Test Name: Oxygen saturation; Result Unstructured Data: Test Result:low; Test Date: 20201223; Test Name: COVID-19 PCR test; Test Result: Positive ; Test Date: 20201223; Test Name: swabs; Result Unstructured Data: Test Result:confirmed COVID infection
CDC Split Type: GBPFIZER INC2021059619

Write-up: swabs confirmed COVID infection; swabs confirmed COVID infection; Dyspnoea; cough; Fall; Agitation; COVID-19 pneumonia; This is a spontaneous report received from a contactable physician by Pfizer from the Regulatory Authority. The regulatory authority report number is GB-MHRA-WEBCOVID-20201231160257, Safety Report Unique Identifier GB-MHRA-ADR 24549450. A 90-year-old male patient received his first BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE) Lot # EJ0553, via an unspecified route of administration on 19Dec2020 at single dose for covid-19 immunisation. Medical history included Coronary artery disease, dementia, osteoarthritis, head injury all from an unknown date and unknown if ongoing, additional medical history included Anaemia, Depression, Gastritis erosive and Rosacea. Concomitant medication included aspirin [acetylsalicylic acid] for Coronary artery disease, atorvastatin for Coronary artery disease, ferrous fumarate for Anaemia, memantine for Dementia, mirtazapine for Depression, omeprazole for Gastritis erosive, oxytetracycline for Rosacea, ramipril for Coronary artery disease. Patient has not had symptoms associated with COVID-19. Patient has not been tested/or has had an inconclusive test for COVID-19. Patient was not enrolled in clinical trial. Patient received COVID-19 (Coronavirus disease 2019) vaccination on 19Dec2020. Subsequently he had a fall on 23Dec2020. He was attended to by the paramedics at home who also noted that he had a cough and breathlessness. He was taken to hospital and swabs confirmed COVID infection on 23Dec2020. COVID-19 PCR test positive. He was admitted on 23Dec2020, although his condition deteriorated and he died on 25Dec2020. He had his first COVID immunisation on 19Dec2020, he had no preceding symptoms at this time. He subsequently had a fall on 23Dec2020 and was noted to be chesty/dyspnoeic by the paramedics and was taken to hospital, where he was admitted. His condition continued to deteriorate, the discharge summary states; ''presented with fall with head injury, shortness of breath (SOB) and cough, low O2 saturations. Tested positive for COVID-19. On examination he had bilateral crepitus. No focal neurological deficit was found on examination, 4 limbs power 5/5/. Patient rapidly deteriorated and required 15L O2. His chest x-ray reported that whilst appearances are most likely to reflect oedema, acute respiratory distress syndrome (ARDS) and atypical infection cannot be excluded. Clinically impression was that patient desaturated due to COVID pneumonia in Dec2020. Patient appeared very agitated in Dec2020 on medical review. As patient was very unwell, NOK was contacted - daughter who has Power Of Attorney (POA) was informed of patient''s poor prognosis and that he was unlikely to survive the illness. Next of kin (NOK) was aware of do-not-attempt-rescuscitation (DNAR) and that patient was forward based care. It was agreed that a trial of treatment would be continued. He was treated with antibiotics and dexamethasone. He unfortunately did not improve with treatment and passed away on 25Dec2020. A postmortem has not been performed. The certified cause of death was unknown at this point in time. The outcome of COVID-19 pneumonia was fatal and for all other events was not resolved. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: COVID-19 pneumonia


VAERS ID: 976487 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2020-12-30
Onset:2021-01-04
   Days after vaccination:5
Submitted: 0000-00-00
Entered: 2021-01-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH NOT.KNOWN / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Death, Drug ineffective, Dyspnoea, Malaise, SARS-CoV-2 test, Vital signs measurement, Vomiting
SMQs:, Anaphylactic reaction (broad), Acute pancreatitis (broad), Lack of efficacy/effect (narrow), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Cardiomyopathy (broad), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-01-13
   Days after onset: 9
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: RIVASTIGMIN [RIVASTIGMINE]
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Cold (had colds before and always got through them); Heart rate low; Parkinson''s disease; Comments: Patient has not had symptoms associated with COVID-19 Patient is not enrolled in clinical trial
Allergies:
Diagnostic Lab Data: Test Date: 20210105; Test Name: COVID-19 virus test; Result Unstructured Data: Test Result:Positive; Test Date: 20210113; Test Name: COVID-19 virus test; Result Unstructured Data: Test Result:Yes - Positive COVID-19 test; Test Name: Vital signs; Result Unstructured Data: Test Result:vitals were giving up
CDC Split Type: GBPFIZER INC2021053413

Write-up: Death; SARS-CoV-2 infection; SARS-CoV-2 infection; Malaise; Dyspnoea; Vomiting; This is a spontaneous report received from a contactable consumer by Pfizer from the Medicines and Healthcare products Regulatory Agency (MHRA). The regulatory authority report number is GB-MHRA-WEBCOVID-202101181625023630 and Safety Report Unique Identifier GB-MHRA-ADR 24610617. An 82-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date was not provided), via an unspecified route of administration on 30Dec2020 at a single dose for COVID-19 vaccination. Medical history included Parkinson''s disease, heart rate decreased, nasopharyngitis (had colds before and always got through them); all unknown if ongoing. Concomitant medication included rivastigmine (RIVASTIGMIN) from 30Dec2020 for Parkinson''s disease. It was reported that the patient had the vaccine on 30Dec2020 and within 4 days (as reported), the patient felt really unwell on 04Jan2021. He then had trouble breathing and also started vomiting 04Jan2021 . He was taken to hospital on 06Jan2021 and then informed and told to expect the worse. His vitals were giving up on an unspecified date. It was reported that the patient was quite strong for his age despite his Parkinson''s disease. It was reported that the patient tested positive for COVID-19 virus test on 05Jan2021 and 13Jan2021. The patient died on 13Jan2021 (also reported as 05Jan2021). An autopsy was not performed. It was reported that the patient was hospitalized due to the events. The outcome of the event SARS-CoV-2 infection was not recovered, while unknown for the events vomiting, dyspnoea and malaise. No follow up attempts are possible; information about batch number cannot be obtained. No further information is expected.; Reported Cause(s) of Death: Death


Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12 13 14   next

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=5&ESORT=AGE&SYMPTOMS=COVID-19&VAX=COVID19&DIED=Yes

Government Disclaimer on use of this data


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166